Nivolumab or Pembrolizumab (dependent upon approved indication): clinical trials recruiting now
Fewer than 3 recruiting trials found.
1
Recruiting trials
8
Conditions studied
1
US states with sites
1
Countries
Phase breakdown
Phase 2 1
Conditions being studied
| Condition | Trials |
|---|---|
| Esophageal Adenocarcinoma | 1 |
| Gastric Adenocarcinoma | 1 |
| HNSCC | 1 |
| Hepatocellular Carcinoma | 1 |
| Melanoma | 1 |
| Microsatellite Instability-High Solid Malignant Tumor | 1 |
| NSCLC | 1 |
| Urothelial Cancer | 1 |
Recruiting trials involving Nivolumab or Pembrolizumab (dependent upon approved indication)
Common questions
How many recruiting trials involve Nivolumab or Pembrolizumab (dependent upon approved indication)?
1 recruiting trial across 8 conditions.
Is this list of trials complete?
No. For the full record, search ClinicalTrials.gov.